← Back
Data updated: Mar 10, 2026
FOURRTS LABS
Pharmaceuticals
FOURRTS LABS is a generic drug manufacturer with 2 FDA-approved products.
2024
Since
2
Drugs
-
Trials
60
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
PREGABALIN 2026-02-24
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-03
Labeling
PREGABALIN 2026-02-02
Labeling
PREGABALIN 2026-02-02
Labeling
PREGABALIN 2025-12-29
Labeling
PREGABALIN 2025-10-01
Labeling
PREGABALIN 2025-10-01
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- 2024-08-13
- Latest
- 2026-02-24
- Applications
- 2